RTU bivalirudin regulatory update

FDA accepted for review an NDA from Eagle for anticoagulant RTU bivalirudin, a ready-to-use formulation of Angiomax bivalirudin from The Medicines Co. (NASDAQ:MDCO, Parsippany, N.J.). The PDUFA date...